| Q37236318 | Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes |
| Q36918192 | Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer |
| Q40223064 | Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk |
| Q57266723 | Association between tamoxifen treatment and diabetes |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q36870645 | Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study |
| Q57910018 | Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women |
| Q37328339 | Biomarkers of the metabolic syndrome and breast cancer prognosis. |
| Q33646525 | CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis |
| Q35104958 | Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations |
| Q36942881 | Cardiometabolic factors and breast cancer risk in U.S. black women |
| Q36278107 | Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study |
| Q34386182 | Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer |
| Q36385281 | Diabetes and breast cancer risk: a meta-analysis. |
| Q34069053 | Diabetes and cancer I: risk, survival, and implications for screening |
| Q38232006 | Diabetes mellitus: influences on cancer risk |
| Q31067247 | HbA1C and cancer risk in patients with type 2 diabetes--a nationwide population-based prospective cohort study in Sweden |
| Q50098159 | Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression. |
| Q33594115 | Hyperglycemia, a neglected factor during cancer progression |
| Q57266717 | Incidence of diabetes among postmenopausal breast cancer survivors |
| Q36841591 | Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus |
| Q45908971 | Influence of diabetes mellitus on mortality in breast cancer patients. |
| Q34424886 | Metformin for aging and cancer prevention |
| Q93017470 | O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity |
| Q36711193 | Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China. |
| Q34078857 | Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states |
| Q36769486 | Pre-diagnosis blood glucose and prognosis in women with breast cancer. |
| Q24645449 | Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet |
| Q47567147 | Protein kinase C δ-dependent regulation of Ubiquitin-proteasome system function in breast cancer |
| Q40600342 | Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes. |
| Q46907663 | Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-The Hong Kong Diabetes Registry |
| Q34346863 | Risk factors of breast cancer: a systematic review and meta-analysis |
| Q35563646 | Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women |
| Q34797196 | Risks of Breast and Endometrial Cancer in Women with Diabetes: A Population-Based Cohort Study. |
| Q91652109 | Role of the Wnt signalling pathway in the development of endothelial disorders in response to hyperglycaemia |
| Q37887304 | Schizophrenia: women bear a disproportionate toll of antipsychotic side effects |
| Q37133664 | Secondary effects of antipsychotics: women at greater risk than men. |
| Q37896624 | Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? |
| Q38017727 | Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies |
| Q36414453 | The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells. |
| Q36060158 | The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project |
| Q44913921 | The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer |
| Q33893799 | The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer |
| Q34888096 | The role of endocrine insulin-like growth factor-I and insulin in breast cancer |
| Q34113485 | The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. |
| Q36582700 | Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk |
| Q35782192 | Use of Insulin and Mortality from Breast Cancer among Taiwanese Women with Diabetes |
| Q42767776 | World congress on insulin resistance, diabetes, and cardiovascular disease: Part 1 |